High Resolution Micro OCT Imaging
The purpose of this study is to learn about using the imaging to make images of the lungs and nose with the long-term goal of the research leading to potential treatments and new therapies for patients with cystic fibrosis.
Conditions:
Cystic Fibrosis COPD PCD - Primary Ciliary Dyskinesia Covid19 Sinusitis
Study Start (Actual) 2016-04-15
Primary Completion (Estimated) 2024-12-31
Study Completion (Estimated) 2024-12-31
Enrollment (Estimated) 60
Study Type OBSERVATIONAL
Phase N/A
Locations:
📍 Birmingham, Alabama, United States

Eligibility Criteria

Description

    Inclusion Criteria:

    • * Patients diagnosed with CF or healthy normal controls with no respiratory disease
    • * Patients must be over the age of 14
    • * Patient must be able to give informed consent

    Exclusion Criteria:

    • * Patients with recent respiratory infection requiring antibiotics or corticosteroids in the last 4 weeks (excluding routine perioperative antibiotics)
    • * Patients with major sinus surgery that will alter the nasal anatomy and preclude imaging of the nares
    • * Any condition that in the opinion of the investigator will alter the safety of pilot testing in the operating room
    • * Female subjects who are pregnant
Ages Eligible for Study: 14 Years to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted2017-08-18
  • First Submitted that Met QC Criteria2017-08-18
  • First Posted2017-08-22

Study Record Updates

  • Last Update Submitted that Met QC Criteria2023-12-06
  • Last Update Posted2023-12-07
  • Last Verified2023-12